Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Zealand Pharma A/S (ZEAL)

NASDAQ:ZEAL

ZEAL

Zealand Pharma

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding ZEAL?

Track your performance easily

Link Broker

Zealand Pharma (ZEAL) Income Statement

0 Followers

Zealand Pharma Income Statement

Last quarter (Q ), Zealand Pharma's total revenue was kr15.08M, an increase of 164.32% from the same quarter last year. In Q, Zealand Pharma's net income was kr-222.84M. See Zealand Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	kr 259.82M	kr 292.57M	kr 353.31M	kr 41.33M	kr 37.98M	kr 136.32M
Cost of Revenue	kr 97.98M	kr 118.81M	kr 90.56M	kr 415.00K	kr 180.24M	kr 14.16M
Gross Profit	kr 161.84M	kr 173.75M	kr 262.75M	kr 40.92M	kr -142.26M	kr 122.16M
Operating Expense	kr 1.18B	kr 1.22B	kr 1.09B	kr 628.86M	kr -794.65M	kr 371.53M
Operating Income	kr -1.01B	kr -1.05B	kr -828.76M	kr -587.94M	kr 652.38M	kr -249.37M
Net Non Operating Interest Income Expense	kr -23.61M	kr -7.52M	kr -6.83M	kr 2.02M	kr -30.79M	kr -31.46M
Other Income Expense	kr 83.48M	kr 30.78M	kr -4.07M	kr 9.24M	kr 3.46M	kr 74.00K
Pretax Income	kr -954.84M	kr -1.03B	kr -839.65M	kr -576.68M	kr 625.05M	kr -280.76M
Tax Provision	kr 2.16M	kr -8.79M	kr 7.08M	kr -5.14M	kr 43.77M	kr -5.50M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr -998.81M	kr -1.02B	kr -846.73M	kr -571.54M	kr 581.28M	kr -275.26M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 1.27B	kr 1.34B	kr 1.18B	kr 629.27M	kr -614.41M	kr 385.69M
Net Income From Continuing And Discontinued Operation	kr -998.81M	kr -1.02B	kr -846.73M	kr -571.54M	kr 581.28M	kr -275.26M
Normalized Income	kr -919.94M	kr -1.05B	kr -843.56M	kr -580.70M	kr 578.06M	kr -275.33M
Interest Expense	kr 20.16M	kr 4.09M	kr 2.90M	kr 3.21M	kr 15.08M	kr 18.91M
EBIT	kr -934.68M	kr -1.02B	kr -836.76M	kr -573.47M	kr 640.13M	kr -261.85M
EBITDA	kr -934.68M	kr -982.60M	kr -836.76M	kr -559.79M	kr 644.64M	kr -257.09M

Currency in DKK

Zealand Pharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing